Bygum, Anette
Martinez-Saguer, Inmaculada
Bas, Murat
Rosch, Jeffrey
Edelman, Jonathan
Rojavin, Mikhail
Williams-Herman, Debora
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert® (C1-INH) Registry
https://doi.org/10.1007/s40266-016-0403-0
Article History
First Online: 4 October 2016
Compliance with Ethical Standards
:
: This study was funded by CSL Behring.
: Dr. Anette Bygum has received consulting fees and travel expenses from CSL Behring and Shire; grants and writing assistance from CSL Behring; fees for participation in reviews and speaker fees as a chairperson for Shire; she has taken an unpaid part in educational events with SOBI; and has provided unpaid writing assistance for ViroPharma. Dr. Inmaculada Martinez-Saguer has received consultancy fees and fees for participation in reviews from CSL Behring, Shire, Sobi, BioCryst, and Pharming. Dr. Murat Bas has received grants, consulting fees, honorarium, and travel support from CSL Behring. Dr. Jeffrey Rosch has no conflicts to disclose. Drs Jonathan Edelman and Mikhail Rojavin are employees at CSL Behring. Dr. Debora Williams-Herman was an employee of CSL Behring at the time of study conduct.